Literature DB >> 1908313

Immunoprophylaxis for rhesus disease--expensive but worth it?

M Selinger.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1908313     DOI: 10.1111/j.1471-0528.1991.tb10360.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


× No keyword cloud information.
  3 in total

1.  Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.

Authors:  J Goodrick; B Kumpel; D Pamphilon; I Fraser; G Chapman; B Dawes; D Anstee
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

2.  Treatment requirements of infants with rhesus isoimmunisation within a geographically defined area.

Authors:  A Greenough; G Hartnoll; H Hambley; J Richards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

3.  Use of anti-D in an accident and emergency department.

Authors:  A M Huggon; D P Watson
Journal:  Arch Emerg Med       Date:  1993-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.